» Articles » PMID: 31202925

Nationwide Surveillance of Antimicrobial Resistance Among Clinically Important Gram-negative Bacteria, with an Emphasis on Carbapenems and Colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018

Abstract

Multicentre surveillance of antimicrobial susceptibility of clinically important Gram-negative bacteria (GNB) from 16 Taiwanese hospitals was performed. Escherichia coli (n = 398), Klebsiella pneumoniae (n = 346), Pseudomonas aeruginosa (n = 252) and Acinetobacter baumannii complex (ABC) (n = 188) bloodstream isolates, non-typhoidal Salmonella (n = 230) and Shigella flexneri (n = 18) from various sources were collected. Antimicrobial MICs were determined using broth microdilution. Genes encoding K. pneumoniae carbapenemases (KPCs), New Delhi metallo-β-lactamases (NDMs), Verona integron-encoded metallo-β-lactamase (VIM), OXA-48-like carbapenemase (OXA-48) as well as mcr-1-5 genes were detected by molecular methods. Rates of carbapenem non-susceptibility were 2.8%, 9.0%, 0.4%, 0%, 10.3% and 48.8% for E. coli, K. pneumoniae, Salmonella, Shigella, P. aeruginosa and ABC, respectively. For carbapenemases, one (0.3%) E. coli harboured bla. Fifteen (4.3%), two (0.6%) and two (0.6%) K. pneumoniae contained bla, bla and bla, respectively. Two (0.5%) E. coli and fourteen (4.0%) K. pneumoniae were non-wild-type according to the colistin MIC. Among Enterobacteriaceae with a colistin MIC ≥ 2 mg/L, mcr-1 was detected in one E. coli, two K. pneumoniae and three Salmonella spp. All three mcr-1-positive Salmonella isolates were collected from community-acquired infections; none of the six mcr-1-positive Enterobacteriaceae were carbapenem-resistant. Carbapenem resistance has increased among clinically important GNB, especially among hospital-acquired infections. bla, especially the bla variant, was detected in approximately one-half of the carbapenem-resistant K. pneumoniae isolates in this study. Although resistance rates to colistin remained low among Enterobacteriaceae, the finding of mcr-1 from different species raises concern of potential dissemination.

Citing Articles

Current trends in the epidemiology of multidrug-resistant and beta-lactamase-producing in Asia and Africa: a systematic review and meta-analysis.

Salleh M, Nik Zuraina N, Deris Z, Mohamed Z PeerJ. 2025; 13:e18986.

PMID: 40017659 PMC: 11867037. DOI: 10.7717/peerj.18986.


Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes KPC, OXA48, VIM and NDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead.

Reinicke M, Diezel C, Teimoori S, Haase B, Monecke S, Ehricht R Int J Mol Sci. 2025; 26(3).

PMID: 39940986 PMC: 11818240. DOI: 10.3390/ijms26031218.


Integrated assessment of mucilage impact on human health using the One Health approach: Prevalence and antimicrobial resistance profiles of and in the Marmara Sea, Türkiye.

Yibar A, Ay H, Aydin F, Abay S, Karakaya E, Kayman T Heliyon. 2025; 11(3):e42103.

PMID: 39916849 PMC: 11800074. DOI: 10.1016/j.heliyon.2025.e42103.


Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study.

Yu C, Tsai M, Liao C, Yang C Infect Drug Resist. 2024; 17:5363-5374.

PMID: 39654695 PMC: 11626955. DOI: 10.2147/IDR.S475679.


Prevalence of colistin resistance in clinical isolates of : a systematic review and meta-analysis.

Narimisa N, Keshtkar A, Dadgar-Zankbar L, Bostanghadiri N, Far Y, Shahroodian S Front Microbiol. 2024; 15:1477836.

PMID: 39473844 PMC: 11520190. DOI: 10.3389/fmicb.2024.1477836.